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A 62-year-old male with long-standing smoking history presented with haemoptysis. 
Plain chest X-ray showed abnormal findings proximate to the right pulmonary hilum. 
Bronchoscopy revealed a fragile exophytic tumour of the right wall of the lower third 
of the trachea, infiltrating the right main bronchus (75% stenosis) and the right upper 
lobar bronchus (near total occlusion). Contrast-enhanced chest computed tomography 
demonstrated a 7.2 × 4.9 cm tumour contiguous to the above-mentioned structures, 
mediastinal lymph node pathology, and a vessel coursing inferiorly to the left of the 
aortic arch and anterior to the left hilum. Despite the tumour constricting the right su-
perior vena cava (SVC), no signs of SVC syndrome were present. In this case, the patient 
does not present with SVC syndrome, as expected due to the constriction of the (right) 
SVC caused by the tumour, since head and neck veins drain through the persistent left 
superior vena cava (PLSVC). PLSVC is the most common thoracic venous anomaly with 
an incidence of 0.3% to 0.5% of the general population and it is a congenital anomaly 
caused by the failure of the left anterior cardinal vein to regress and to consequently 
form the ligament of Marshall during foetal development. It is associated with absence 
of the left brachiocephalic vein and in 10% to 20% of cases the right SVC is absent. Two 
potential draining points of the PLSVC have been previously reported. In the majority of 
cases PLSVC drains directly into the coronary sinus, but less frequently it drains into the 
left atrium or the left superior pulmonary vein (LSPV). In cases where the PLSVC drains 
into the coronary sinus, congenital heart defects are rare. The patient usually remains 
asymptomatic and PLSVC is an incidental finding during radiographic imaging or medical 
procedures. When the PLSVC drains into the left atrium or the LSPV, a right-to-left shunt 
is formed; a condition usually asymptomatic. In some reported cases this PLSVC variant 
presents with persistent, unexplained hypoxia or cyanosis and embolisation causing 
recurrent transient ischaemic attacks and/or cerebral abscesses. This PLSVC variant is 
more often associated with absence of the right SVC and congenital heart abnormalities. 
(Folia Morphol 2017; 76, 4: 748–751)
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INTRODUCTION
Persistent left superior vena cava (PLSVC) is the 
most frequent congenital malformation of the tho-
racic venous system, as it affects 0.3–0.5% of the 
general population [2]. Approximately 4.5% of pa-
tients with a congenital heart disease (CHD) present 
with PLSVC [2, 15]. 
The term superior vena cava syndrome (SVCS) de-
scribes the various symptoms and signs of head and 
neck venous congestion, caused by obstruction of the 
superior vena cava (SVC) or innominate veins [19]. 
In 60% of all SVCS cases, the SVC is obstructed by 
a malignant tumour of the lung and mediastinum [13]. 
SVCS patients have a feeling of fullness in the head that 
is exacerbated when bending over or lying flat in bed. 
Other symptoms and physical signs might coexist and 
their severity depends on the degree of SVC stenosis. 
In this case we present a patient with PLSVC, 
diagnosed incidentally during thoracic computed 
tomography (CT) for a tracheal tumour constricting 
the right SVC.
CASE REPORT
A 62-year-old male with long-standing smoking 
history presented with haemoptysis. His past medical 
history included atrial fibrillation under oral antico-
agulants. 
A plain chest X-ray showed abnormal findings 
proximate to the right pulmonary hilum. His anti-
coagulation prophylaxis was halted due to continu-
ing haemoptysis and a diagnostic plan to undergo 
bronchoscopy.
Contrast-enhanced chest CT demonstrated a tu-
mour adjacent to the right tracheal wall, the right 
main bronchus and the right upper lobar bronchus. 
The CT study also demonstrated an anomalous vessel 
coursing inferiorly to the left of the arch of the aorta 
and anterior to the left hilum (Figs. 1, 2).
Bronchoscopy revealed a fragile exophytic tumour, 
7.2 × 4.9 cm in size, adjacent to the right wall of 
the lower third of the trachea, also infiltrating the 
right main bronchus (75% stenosis) and the right up-
per lobar bronchus (near total occlusion; not letting 
the endoscopic fibre pass). Bronchoalveolar lavage 
material and bronchial secretions were collected for 
cytological analysis. No biopsies were collected due 
to the fragile nature of the tumour and its bleeding 
predisposal.
Despite the tumour constricting the right SVC, 
no signs of SVCS were present. The patient’s only 
complaint continued to be haemoptysis and therefore 
his oral anticoagulation regime has to be altered.
The patient suffered a severe ischaemic stroke 
before any procedure was undertaken regarding his 
thoracic tumour and he passed 6 days later.
DISCUSSION
Persistent left superior vena cava affects 0.3–0.5% 
of the general population [2]. Cardiac malforma- 
tions, such as atrial septal defect or tetralogy of Fal-
lot, are present in approximately half of all patients 
with PLVSC [15]. In the majority of PLSVC patients, 
right SVC is present, but in 0.09–0.13% of patients 
with CHD, right SVC is absent and only PLVSC is 
Figure 2. Coronal computed tomography cross section; arrow  
indicates left superior cava vein.
Figure 1. Transverse computed tomography cross section; arrow 
indicates left superior cava vein.
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present [17]. PLSVC is a persistent remnant of an early 
embryonic vessel, which could be described as a left 
SVC, and normally disappears as the embryo matures 
[8, 15]. When detected in foetal life, PLSVC needs 
repeated follow-ups and constant inspection of the 
foetal anatomy, as it is frequently associated with het-
erotaxy syndromes and other malformations. Isolated 
PLSVC is a benign vascular anomaly and is usually 
asymptomatic and is detected when cardiovascu-
lar imaging is performed for unrelated reasons [5]. 
Diagnosis of PLSVC is relatively easy with contrast-
enhanced chest CT. Ventilation/perfusion scan could 
be of diagnostic value, only in cases where the PLSVC 
directly drains into the left atrium [12]. Plain chest 
X-ray can be misleading. Treatment is not necessary if 
CHD is not present and adequate left-to-right venous 
shunt exists.
Superior vena cava syndrome presents with a va-
riety of symptoms, including dyspnoea on exertion, 
orthopnoea, headache, dizziness, syncope, or visual 
complaints and cough [19]. The most common com-
plaint is a feeling of fullness in the head and neck, 
exacerbated when bending over or lying flat in bed. 
Physical signs of SVCS may include enlarged chest wall 
venous collaterals, facial and neck swelling, facial cya-
nosis, arm swelling and pleural effusion [1, 10, 14, 19]. 
Although the majority of SVCS are caused by malig-
nant tumours, thrombosis of the SVC secondary to 
central venous catheter or pacemaker placement could 
potentially be the cause [9, 13]. Other causes are less 
frequent. CT angiography and magnetic-resonance ve-
nography (MRV) are both considered valuable methods 
in diagnosing SVCS. Ultrasonography of the jugular 
and the subclavian veins is an indirect noninvasive 
method to check SVC patency. Plain chest X-ray can 
set the diagnosis in the majority of cases, although 
this is based on indirect findings and a negative X-ray 
does not exclude SVCS as a diagnosis [10]. Contrast-
enhanced venography through simultaneous injection 
of contrast through the superficial veins of both the up-
per arms is the gold standard for setting the diagnosis 
of SVCS [18]. Treatment includes conservative meas-
ures, daily activity modification and anticoagulants. 
In cases of malignancy, chemotherapy, irradiation and 
combined chemoradiotherapy frequently improve pa-
tients’ symptoms. Open surgical repair through a me-
dian sternotomy in SVCS cases caused by malignancy 
should be performed only if life expectancy exceeds 
1 year [3, 4, 7, 11]. Endovascular stenting of the SVC 
is an alternative that becomes widely available [6, 16]. 
Extra-anatomic bypass between the jugular and the 
femoral veins is an alternative if symptoms are severe 
and endovascular techniques fail or are not possible. 
CONCLUSIONS
In our case, the right SVC is almost totally ob-
structed by the mediastinal tumour and the presence 
of PLSVC came to the patient’s assistance, as no signs 
of SVCS developed. The PLSVC drained part of the 
head and neck blood flow back to the heart, thus 
decreasing the load to the right SVC. In this case, 
the therapeutic approach was to use the PLSVC as 
a temporary measure of symptom relief, until the 
mediastinal tumour was either excised or subjected 
to adjuvant conservative therapy depending on the 
tumours histology. 
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